Multiple Genetic Changes Can Occur in the Oral Poliovaccines upon Replication in Humans

References

1. Butterworth B. E. 1973; A comparison of the virus-specific polypeptides of encephalomyocarditis virus, human rhinovirus-1A, and poliovirus. Virology 56:439–453
   [Google Scholar]
2. Cooper P. D. 1969; The genetic analysis of poliovirus. In The Biochemistry of Viruses pp 177–218 Edited by Levy H. B. New York: Marcel Dekker;
   [Google Scholar]
3. Domingo E., Sabo D., Taniguchi T., Weissmann C. 1978; Nucleotide sequence heterogeneity of an RNA phage population. Cell 13:735–744
   [Google Scholar]
4. Flanegan J. B., Baltimore D. 1979; Poliovirus polyuridylic acid polymerase and RNA replicase have the same viral polypeptide. Journal of Virology 29:352–360
   [Google Scholar]
5. Jarzabek Z., Sadowski W., Kantoch M., Magrath D., Krawczynski K. 1976; Studies on the characteristics of poliovirus type 3. III. Strain characteristics after passage in man. Acta Virologica 20:373–379
   [Google Scholar]
6. Kew O. M., Pallansch M. A., Omilianowski D. R., Rueckert R. R. 1980; Changes in three of the four coat proteins of oral poliovaccine strain derived from type 1 poliovirus. Journal of Virology 33:256–263
   [Google Scholar]
7. Lee Y. F., Kitamura N., Nomoto A., Wimmer E. 1979; Sequence studies of poliovirus RNA. IV. Nucleotide sequence complexities of poliovirus type 1, type 2 and two type 1 defective interfering particle RNAs, and fingerprint of the poliovirus type 3 genome. Journal of General Virology 44:311–322
   [Google Scholar]
8. Melnick J. L. 1961; Attenuated poliovirus vaccine: virus stability. In Poliomyelitis. Fifth International Poliomyelitis Conference, Copenhagen pp 384–402 Philadelphia: Lippincott;
   [Google Scholar]
9. Minor P. D. 1980; Comparative biochemical studies of type 3 poliovirus. Journal of Virology 34:73–84
   [Google Scholar]
10. Nakano J. H., Gelfand H. M., Cole J. T. 1963; The use of a modified Wecker technique for the serodifferentiation of type 1 polioviruses related and unrelated to Sabin’s vaccine strain. II. Antigenic segregation of isolates from specimens collected in field studies. American Journal of Hygiene 78:214–226
    [Google Scholar]
11. Nakano M., Matsukura T., Yoshii K., Komatsu T., Mukoyama A., Uchida N., Kodama H., Tagaya I. 1979; Genetical analysis on the stability of poliovirus type 3 Leon 12 a₁b. Journal of Biological Standardization 7:157–168
    [Google Scholar]
12. Nomoto A., Kajigaya S., Suzuki K., Imura N. 1979; Possible point mutation sites in LSc 2ab poliovirus RNA and a protein covalently linked to the 5′-terminus. Journal of General Virology 45:107–117
    [Google Scholar]
13. Nottay B. K., Kew O. M., Hatch M. H., Heyward J. T., Obijeski J. F. 1981; Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology 107:405–423
    [Google Scholar]
14. Paccaud M. F. 1979; World trends in poliomyelitis morbidity and mortality, 1951–1975. World Health Statistics Annual 32:198–224
    [Google Scholar]
15. Palmenberg A. C., Pallansch M. A., Rueckert R. R. 1979; Protease required for processing picornaviral coat protein resides in the viral replicase gene. Journal of Virology 32:770–778
    [Google Scholar]
16. Rueckert R. R., Matthews T. J., Kew O. M., Pallansch M. A., Mclean C., Omilianowskl D. 1979; Synthesis and processing of picornaviral polyprotein. In Molecular Biology of Picornaviruses pp 113–125 Edited by Perez-Bercoff R. New York: Plenum Press;
    [Google Scholar]
17. Sabin A. B. 1957; Properties and behaviour of orally administered attenuated poliovirus vaccine. Journal of the American Medical Association 164:1216–1223
    [Google Scholar]
18. Sabin A. B., Boulger L. R. 1973; History of Sabin attenuated poliovirus oral live vaccine strains. Journal of Biological Standardization 1:115–118
    [Google Scholar]
19. Schonberger L. B., McGowan J. E. Jr, Gregg M. B. 1976; Vaccine-associated poliomyelitis in the United States. American Journal of Epidemiology 104:202–211
    [Google Scholar]